Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis
Francesca Boldrin, Roberta Provvedi, Laura Cioetto Mazzabò, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Véronique Dartois, Eric J. Rubin
Nature Reviews Microbiology (2022) Vol. 20, Iss. 11, pp. 685-701
Open Access | Times Cited: 329
Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment
Anna Allué‐Guardia, Juan Ignacio García, Jordi B. Torrelles
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 168
Biofilms: Understanding the structure and contribution towards bacterial resistance in antibiotics
Pallee Shree, Chandra Kant Singh, Kushneet Kaur Sodhi, et al.
Medicine in Microecology (2023) Vol. 16, pp. 100084-100084
Open Access | Times Cited: 161
Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung
Davide Pisu, Lu Huang, Vipin Narang, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 9
Open Access | Times Cited: 119
How macrophage heterogeneity affects tuberculosis disease and therapy
David G. Russell, Nelson V. Simwela, Joshua T. Mattila, et al.
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 4
Targeting Mycobacterium tuberculosis Persistence through Inhibition of the Trehalose Catalytic Shift
Karishma Kalera, Rachel Liu, Ju‐Hyeon Lim, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1391-1404
Open Access | Times Cited: 9
Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex
Ge Xu, Hangchi Liu, Xudong Jia, et al.
Tuberculosis (2021) Vol. 128, pp. 102083-102083
Closed Access | Times Cited: 39
Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
Sam Afkhami, Michael R. D’Agostino, Maryam Vaseghi‐Shanjani, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus
Kaixi Zhang, Jakkarin Limwongyut, Alex S. Moreland, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 735
Open Access | Times Cited: 5
Mechanisms of a Mycobacterium tuberculosis Active Peptide
Komal Umashankar Rao, Ping Li, Charlotte Welinder, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 540-540
Open Access | Times Cited: 12
Role of the Extracytoplasmic Function Sigma Factor SigE in the Stringent Response of Mycobacterium tuberculosis
Giacomo Baruzzo, Agnese Serafini, Francesca Finotello, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 10
Noise in a Metabolic Pathway Leads to Persister Formation in Mycobacterium tuberculosis
Jeffrey Quigley, Kim Lewis
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 16
SigE: A master regulator of Mycobacterium tuberculosis
Riccardo Manganelli, Laura Cioetto-Mazzabò, Greta Segafreddo, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Mycobacterium abscessus DosRS two-component system controls a species-specific regulon required for adaptation to hypoxia
Breven S. Simcox, Brooke R. Tomlinson, Lindsey N. Shaw, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Activity of Drug Combinations against Mycobacterium abscessus Grown in Aerobic and Hypoxic Conditions
Alessio Lanni, Emanuele Borroni, Angelo Iacobino, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1421-1421
Open Access | Times Cited: 12
Are all antibiotic persisters created equal?
Michael W. Shultis, Claire V. Mulholland, Michael Berney
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 12
Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
Sydney Stanley, Qingyun Liu, Sarah M. Fortune
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 11
Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistance
Ashirbad Sarangi, Manisha Singh, B. S. Das, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32003-e32003
Open Access | Times Cited: 2
Immune Targeting of Mycobacteria through Cell Surface Glycan Engineering
Priscilla Dzigba, Adrian K. Rylski, Isaac J. Angera, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 7, pp. 1548-1556
Closed Access | Times Cited: 5
Bacterial survivors: evaluating the mechanisms of antibiotic persistence
Xiaoyi Shi, Ashraf Zarkan
Microbiology (2022) Vol. 168, Iss. 12
Closed Access | Times Cited: 9
The treatment effect of Levofloxacin, Moxifloxacin, and Gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis
Yiyue He, Xiaofei Li
Medicine (2022) Vol. 101, Iss. 38, pp. e30412-e30412
Open Access | Times Cited: 7
Mathematical modelling of SigE regulatory network reveals new insights into bistability of mycobacterial stress response
Irene Zorzan, Simone Del Favero, Alberto Giaretta, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Multitargeting: An Alternative Approach to Tackle Multidrug Resistance in Tuberculosis
Satakshi Hazra, Risha Hazarika, Sanjukta Patra
Current Drug Targets (2023) Vol. 24, Iss. 9, pp. 751-775
Closed Access | Times Cited: 3
Tale of Twin Bifunctional Second Messenger (p)ppGpp Synthetases and Their Function in Mycobacteria
Shubham Kumar Sinha, Neethu RS, Yogeshwar Devarakonda, et al.
ACS Omega (2023) Vol. 8, Iss. 36, pp. 32258-32270
Open Access | Times Cited: 3
Mycobacterium tuberculosis ketol-acid reductoisomerase down-regulation affects its ability to persist, and its survival in macrophages and in mice
Nirbhay Singh, Anu Chauhan, Ram Kumar, et al.
Microbes and Infection (2022) Vol. 24, Iss. 8, pp. 105000-105000
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top